Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kenneth K W To

Showing results (1-10 of 100) with videos related to

Pageof 10
Sort By:
Journal of Biomedical Science|December 24, 2013
MicroRNA: a prognostic biomarker and a possible druggable target for circumventing multidrug resistance in cancer chemotherapyKenneth K W To
British Journal of Pharmacology|September 17, 2013
Targeting the ABCG2-overexpressing multidrug resistant (MDR) cancer cells by PPARγ agonistsKenneth K W To, Brian Tomlinson
Recent Patents on Anti-Cancer Drug Discovery|January 8, 2021
Repurposing Chloroquine Analogs as an Adjuvant Cancer TherapyWinnie Fong, Kenneth K W To
Clinical and Translational Science|October 30, 2024
Serum creatine kinase elevation following tyrosine kinase inhibitor treatment in cancer patients: Symptoms, mechanism, and clinical managementHang Zhang, Kenneth K W To
Cellular and Molecular Life Sciences : CMLS|May 16, 2019
Drug repurposing to overcome resistance to various therapies for colorectal cancerWinnie Fong, Kenneth K W To
Investigational New Drugs|August 19, 2017
CUDC-907, a dual HDAC and PI3K inhibitor, reverses platinum drug resistanceKenneth K W To, Li-Wu Fu
Methods in Molecular Biology (Clifton, N.J.)|September 6, 2013
An efficient way of studying protein-protein interactions involving HIF-α, c-Myc, and Sp1Kenneth K-W To, L Eric Huang
The Journal of Biological Chemistry|September 15, 2005
Suppression of hypoxia-inducible factor 1alpha (HIF-1alpha) transcriptional activity by the HIF prolyl hydroxylase EGLN1Kenneth K W To, L Eric Huang
Pharmaceutics|August 26, 2023
Drug Repurposing to Circumvent Immune Checkpoint Inhibitor Resistance in Cancer ImmunotherapyKenneth K W To, William C Cho
Current Cancer Drug Targets|February 4, 2021
Flavonoids Overcome Drug Resistance to Cancer Chemotherapy by Epigenetically Modulating Multiple MechanismsKenneth K W To, William C S Cho
Pageof 10

Showing results (1-10 of 100) with videos related to

Sort By:
Pageof 10
Journal of Biomedical Science|December 24, 2013
MicroRNA: a prognostic biomarker and a possible druggable target for circumventing multidrug resistance in cancer chemotherapyKenneth K W To
British Journal of Pharmacology|September 17, 2013
Targeting the ABCG2-overexpressing multidrug resistant (MDR) cancer cells by PPARγ agonistsKenneth K W To, Brian Tomlinson
Recent Patents on Anti-Cancer Drug Discovery|January 8, 2021
Repurposing Chloroquine Analogs as an Adjuvant Cancer TherapyWinnie Fong, Kenneth K W To
Clinical and Translational Science|October 30, 2024
Serum creatine kinase elevation following tyrosine kinase inhibitor treatment in cancer patients: Symptoms, mechanism, and clinical managementHang Zhang, Kenneth K W To
Cellular and Molecular Life Sciences : CMLS|May 16, 2019
Drug repurposing to overcome resistance to various therapies for colorectal cancerWinnie Fong, Kenneth K W To
Investigational New Drugs|August 19, 2017
CUDC-907, a dual HDAC and PI3K inhibitor, reverses platinum drug resistanceKenneth K W To, Li-Wu Fu
Methods in Molecular Biology (Clifton, N.J.)|September 6, 2013
An efficient way of studying protein-protein interactions involving HIF-α, c-Myc, and Sp1Kenneth K-W To, L Eric Huang
The Journal of Biological Chemistry|September 15, 2005
Suppression of hypoxia-inducible factor 1alpha (HIF-1alpha) transcriptional activity by the HIF prolyl hydroxylase EGLN1Kenneth K W To, L Eric Huang
Pharmaceutics|August 26, 2023
Drug Repurposing to Circumvent Immune Checkpoint Inhibitor Resistance in Cancer ImmunotherapyKenneth K W To, William C Cho
Current Cancer Drug Targets|February 4, 2021
Flavonoids Overcome Drug Resistance to Cancer Chemotherapy by Epigenetically Modulating Multiple MechanismsKenneth K W To, William C S Cho
Pageof 10